share_log

荣昌生物(09995)拟使用不超过3亿元的自有资金购买理财产品

Rongchang Biotech (09995) plans to use no more than 300 million yuan of its own funds to purchase wealth management products

Zhitong Finance ·  Mar 27 19:18

Rongchang Biotech (09995) announced that the company held the 2nd board meeting on March 27, 2024...

Zhitong Finance App News, Rongchang Biotech (09995) announced that on March 27, 2024, the company held the 11th meeting of the 2nd board of directors and the 8th meeting of the 2nd board of supervisors to review and pass the “Proposal on Using Own Funds for Cash Management”, agreeing that the company will use no more than RMB 300 million of its own capital to purchase financial products with high security, good liquidity, and purchasing institutions are not limited to banks, securities companies and other financial institutions for cash management.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment